Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 33, 2019 - Issue 20
264
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

A new indole-type alkaloid from the roots of Clematis florida var. plena

, , , , , , , , & show all
Pages 2925-2931 | Received 01 May 2018, Accepted 12 Jul 2018, Published online: 05 Dec 2018
 

Abstract

One new indole-type alkaloid, α-L-rhamnopyranosyl-(1→6)-β-D- glucopyranosyl 6-methoxy-3-indolecarbonate (1), together with three known alkaloids (24), one aromatic acid (5) and five known saponins (610), was isolated from the roots of Clematis florida var. plena. Their structures were established by NMR spectroscopic analysis and acid hydrolysis. In in vivo anti-inflammatory activity, n-butanol extract was found to be potent against ear edema in mice, with inhibition rate of 48.7% at a dose of 800 mg/kg. Furthermore, compounds 8 and 9 obtained from the n-butanol extract exhibited significant anti-inflammatory activities with inhibition rates of 50.9% and 54.7% at a dose of 200 mg/kg.

Graphical Abstract

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was financially supported by the Natural Science Foundation of Fujian Province [grant number 2016J01369], [grant number 2018J01847]; the Open Project of National Marine Bureau Key Laboratory of Marine Biogenetic Resources [grant number HY201807], [grant number HY201604]; the Science and technology innovation platform project of Fujian Province [grant number 2018Y2001].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.